{
  "reviewed": "2026-09-23",
  "scope": "Selected major claims and clinical context; not a systematic review or medical advice",
  "claims": [
    {
      "id": "source-role",
      "claim": "Terry is the third Neuralink recipient",
      "assessment": "Correction: third VOICE participant",
      "finding": "The official film specifies third in the VOICE speech study, not third overall. The film release date is not his confirmed implant date.",
      "sources": [
        "https://www.youtube.com/watch?v=_j806JHhCRo"
      ]
    },
    {
      "id": "communication",
      "claim": "Terry can communicate through decoded speech",
      "assessment": "Company demonstration, not a complete outcomes report",
      "finding": "The film describes intended-speech decoding and computer output. Residual mouth/body movement is acknowledged. This is not reversal of ALS or restored biological vocal function.",
      "sources": [
        "https://www.youtube.com/watch?v=_j806JHhCRo",
        "https://neuralink.com/trials/speech-restoration/"
      ]
    },
    {
      "id": "imagined-speech",
      "claim": "The system progressed from attempted to imagined words",
      "assessment": "Company-reported progression",
      "finding": "Description/post say miming first, then thinking words. The film includes attempted-speech calibration. No controlled comparison with spontaneous inner speech or unrestricted mind-reading result was supplied.",
      "sources": [
        "https://x.com/neuralink/status/2100993363403063404"
      ]
    },
    {
      "id": "grok-voice",
      "claim": "Grok Voice recreates a familiar voice",
      "assessment": "Primary company attribution, technical details limited",
      "finding": "Official post credits Grok Voice. Exact voice recordings, fidelity and architecture are not established; do not say Grok itself decodes neural signals.",
      "sources": [
        "https://x.com/neuralink/status/2100993363403063404"
      ]
    },
    {
      "id": "trial",
      "claim": "VOICE has proven broad clinical safety and efficacy",
      "assessment": "Not established",
      "finding": "NCT07224256: early feasibility, single-group/open-label, six estimated participants, adverse events as primary outcomes and no posted results. Current served record last updated November 4, 2025.",
      "sources": [
        "https://clinicaltrials.gov/study/NCT07224256",
        "https://clinicaltrials.gov/api/v2/studies/NCT07224256"
      ]
    },
    {
      "id": "peer-reviewed",
      "claim": "Other speech-BCI metrics measure Neuralink performance",
      "assessment": "Incorrect attribution",
      "finding": "Three selected papers involve two distinct participants and other systems. Card/Wairagkar share the ALS participant. Task-specific metrics are not interchangeable.",
      "sources": [
        "https://pubmed.ncbi.nlm.nih.gov/39141853/",
        "https://www.nature.com/articles/s41593-025-01905-6",
        "https://pmc.ncbi.nlm.nih.gov/articles/PMC12369848/"
      ]
    },
    {
      "id": "canada",
      "claim": "CAN-PRIME makes the same speech product available in Canada",
      "assessment": "Different investigational protocol",
      "finding": "UHN and NCT06700304 describe external-device-control research. The reviewed VOICE record names a U.S. site. No Canadian VOICE or routine speech-product access established.",
      "sources": [
        "https://clinicaltrials.gov/study/NCT06700304",
        "https://www.uhn.ca/corporate/News/PressReleases/Pages/uhn-selected-canadian-site-for-can-prime-study-clinical-trial-involving-neuralink.aspx"
      ]
    },
    {
      "id": "regulation",
      "claim": "Trial permission or designation equals product approval",
      "assessment": "Incorrect equivalence",
      "finding": "Company states investigational/not approved. FDA separates expedited review from marketing safety/effectiveness requirements. No specific designation date asserted.",
      "sources": [
        "https://www.fda.gov/medical-devices/how-study-and-market-your-device/breakthrough-devices-program",
        "https://www.youtube.com/watch?v=_j806JHhCRo"
      ]
    },
    {
      "id": "privacy",
      "claim": "Interest registry is trial enrollment or complete neural-data consent",
      "assessment": "Incorrect equivalence",
      "finding": "March 27, 2025 notice says registration is neither enrollment nor a prerequisite. Research requires separate consent. Registry terms do not establish all implant-data or voice-model terms.",
      "sources": [
        "https://neuralink.com/patient-registry-privacy-notice/"
      ]
    },
    {
      "id": "current-options",
      "claim": "People must wait for brain implants to communicate",
      "assessment": "Not supported",
      "finding": "SLP assessment, AAC boards/devices, eye/head/switch access and voice/message banking already exist; individual suitability and regional access vary.",
      "sources": [
        "https://www.als.org/navigating-als/living-with-als/therapies-care/augmentative-alternative-communication",
        "https://alsnetwork.org/understanding-als/living-with-als/guides-for-daily-living/als-communication-devices"
      ]
    }
  ]
}